✦ LIBER ✦

A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma

✍ Scribed by M.R. VALERIO; P. TAGLIAFERRI; F. RASPAGLIESI; F. FULFARO; G. BADALAMENTI; C. ARCARA; G. CICERO; A. RUSSO; S. VENUTA; G. GUARNERI; N. GEBBIA

Book ID: 109085585
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 106 KB
Volume: 16
Category: Article
ISSN: 1048-891X
DOI: 10.1111/j.1525-1438.2006.00324.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II and pharmacokinetic study of

A phase II and pharmacokinetic study of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma

✍ Ruey-Long Hong; Yun-Long Tseng 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 200 KB

Phase II study of the combination of peg

Phase II study of the combination of pegylated liposomal doxorubicin and topotecan in platinum-resistant ovarian cancer

✍ M. VERHAAR-LANGEREIS; A. KARAKUS; M. Van EIJKEREN; E. VOEST; E. WIT 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Pegylated liposomal doxorubicin and gemc

Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study

✍ Adamo, V; Lorusso, V; Rossello, R; Adamo, B; Ferraro, G; Lorusso, D; Condemi, G; 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 126 KB

Pegylated liposomal doxorubicin as secon

Pegylated liposomal doxorubicin as second-line therapy in the treatment of patients with advanced classic Kaposi sarcoma : A retrospective study

✍ Giuseppe Di Lorenzo; Rossella Di Trolio; Vincenzo Montesarchio; Giovanna Palmier 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

## Abstract ## BACKGROUND. Classic Kaposi sarcoma (CKS) is a rare neoplasm that predominantly occurs in elderly subjects and has a variable clinical evolution. The clinical course is usually indolent, but occasionally the neoplasm progresses rapidly and spreads to internal organs, necessitating sy

Α multicenter phase II study of pegylate

Α multicenter phase II study of pegylated liposomal doxorubicin in combination with irinotecan as second-line treatment of patients with refractory small-cell lung cancer

✍ Nikolaos Xenidis; Nikolaos Vardakis; Ioannis Varthalitis; Stylianos Giassas; Emm 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 205 KB

Phase II study of liposomal doxorubicin

Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer

✍ D'Agostino, G; Ferrandina, G; Ludovisi, M; Testa, A; Lorusso, D; Gbaguidi, N; Br 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 87 KB